Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Ann Med Res . 2021;28(11):2065-2070. Accessed May 9, 2025. http://www.annalsmedres.org/index.php/aomr/article/view/3977